Literature DB >> 6349398

Entry of Plasmodium berghei sporozoites into cultured cells, and their transformation into trophozoites.

M R Hollingdale, P Leland, J L Leef, A L Schwartz.   

Abstract

The attachment and entry of Plasmodium berghei sporozoites to cultured human lung fibroblast (WI38) or hepatoma (HepG2-A16) cells in vitro has been visualized using an immunoperoxidase technique coupled with light microscopy. Attachment and entry was substantially more frequent with HepG2-A16 cells, and appeared to be mediated by the Pb44 sporozoite surface protective antigen. When sporozoites were incubated with intact monoclonal antibodies to Pb44 or their monovalent Fab fragments, attachment was inhibited, suggesting that this technique may be an in vitro assay of protective immunity. Sporozoites appeared to enter cells actively, rather than by cell phagocytosis. Once within a membrane-bound vacuole, the sporozoite transformed into a trophozoite. It was suggested that Pb44 recognized a specific cell receptor, and that this technique may permit receptor characterization.

Entities:  

Mesh:

Year:  1983        PMID: 6349398     DOI: 10.4269/ajtmh.1983.32.685

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Plasmodium yoelii sporozoites infect CD36-deficient mice.

Authors:  Photini Sinnis; Maria Febbraio
Journal:  Exp Parasitol       Date:  2002-01       Impact factor: 2.011

2.  Early hepatic stages of Plasmodium berghei: release of circumsporozoite protein and host cellular inflammatory response.

Authors:  Z M Khan; C Ng; J P Vanderberg
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry.

Authors:  Photini Sinnis; Patricia De La Vega; Alida Coppi; Urszula Krzych; Maria M Mota
Journal:  Methods Mol Biol       Date:  2013

4.  Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.

Authors:  Sebastian A Mikolajczak; John B Sacci; Patricia De La Vega; Nelly Camargo; Kelly VanBuskirk; Urszula Krzych; Jun Cao; Marcelo Jacobs-Lorena; Alan F Cowman; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2011-06-24       Impact factor: 3.715

5.  Extrahepatic exoerythrocytic forms of rodent malaria parasites at the site of inoculation: clearance after immunization, susceptibility to primaquine, and contribution to blood-stage infection.

Authors:  Tatiana Voza; Jessica L Miller; Stefan H I Kappe; Photini Sinnis
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

6.  Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies.

Authors:  M J Stewart; R J Nawrot; S Schulman; J P Vanderberg
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

7.  Transformation of sporozoites of Plasmodium berghei into exoerythrocytic forms in the liver of its mammalian host.

Authors:  J F Meis; J P Verhave; P H Jap; J H Meuwissen
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

Review 8.  The biology of tissue forms and other asexual stages in mammalian plasmodia.

Authors:  J P Verhave; J F Meis
Journal:  Experientia       Date:  1984-12-15

9.  Cultivation of the exoerythrocytic stage of Plasmodium berghei in primary cultures of mouse hepatocytes and continuous mouse cell lines.

Authors:  G W Long; S Leath; R Schuman; M R Hollingdale; W R Ballou; B K Sim; S L Hoffman
Journal:  In Vitro Cell Dev Biol       Date:  1989-09

10.  Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design.

Authors:  Kelley M VanBuskirk; Matthew T O'Neill; Patricia De La Vega; Alexander G Maier; Urszula Krzych; Jack Williams; Megan G Dowler; John B Sacci; Niwat Kangwanrangsan; Takafumi Tsuboi; Norman M Kneteman; Donald G Heppner; Brant A Murdock; Sebastian A Mikolajczak; Ahmed S I Aly; Alan F Cowman; Stefan H I Kappe
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.